Dang Lihong, Rehman Ata Ur, Zhang Jin, Zhang Ran, Yu Xinyuan, Sheng Huaxin, Karhausen Jörn, Yang Wei
Multidisciplinary Brain Protection Program (MBPP), Department of Anesthesiology, Duke University Medical Center, Durham, NC, USA.
Shock. 2025 Jun 6. doi: 10.1097/SHK.0000000000002640.
Sudden cardiac arrest (CA) is associated with high mortality and morbidity rates, largely due to detrimental effects of global ischemia on every organ. Notably, clinical evidence indicates that gastrointestinal tract damage is frequently observed in successfully resuscitated CA patients and suggests that this damage has a negative impact on prognosis. However, experimental CA studies have rarely examined this clinically relevant pathologic change and as such, little is known about the underlying mechanisms. Here, we provide the first evidence that mast cells (MCs) play a critical role in gut damage after CA. Our data first showed notable activation of intestinal MCs and evidence of disrupted gut integrity following CA in a mouse model. Then, using both pharmacologic and genetic tools, we found that treatment with the MC activator C48/80 significantly increased gut permeability, while gut function was better preserved in MC-deficient mice compared to wild-type mice. Together, our results identified MC activation as a critical pathologic process driving post-CA gut damage.
心脏骤停(CA)与高死亡率和发病率相关,这主要是由于全身缺血对各个器官的有害影响。值得注意的是,临床证据表明,在成功复苏的CA患者中经常观察到胃肠道损伤,并且表明这种损伤对预后有负面影响。然而,实验性CA研究很少检查这种临床相关的病理变化,因此,对其潜在机制知之甚少。在这里,我们提供了第一个证据,即肥大细胞(MCs)在CA后的肠道损伤中起关键作用。我们的数据首先显示了在小鼠模型中CA后肠道MCs的显著激活以及肠道完整性破坏的证据。然后,使用药理学和遗传学工具,我们发现用MC激活剂C48/80治疗显著增加了肠道通透性,而与野生型小鼠相比,MC缺陷小鼠的肠道功能得到了更好的保留。总之,我们的结果确定MC激活是驱动CA后肠道损伤的关键病理过程。